摘要
目的：探析戈舍瑞林联合比卡鲁胺片治疗前列腺癌的临床效果。方法以2014年2月～2015年2月在我院接受治疗的66例前列腺癌患者作为研究对象，将其分为对照组和观察组，每组各33例患者，其中对照组患者给予戈舍瑞林治疗，观察组患者给予戈舍瑞林联合比卡鲁胺片治疗，对比两组患者的临床疗效以及不良反应情况。结果通过治疗对照组患者的不良反应发生率为12.12%，观察组患者不良反应发生率为9.09%，比较差异无统计学意义，P＞0.05；两组患者的前列腺特异性抗原值比较观察组要优于对照组，且P＜0.05，差异有统计学意义。结论临床上使用戈舍瑞林联合比卡鲁胺片治疗前列腺癌是一种有效的方法，取得比较良好的治疗效果，且使用的耐药性和安全性较高。
Objective The clinical effect of zoladex combined casodex in treatment for prostate cancer.Methods From February 2014 to February 2015,66 cases of prostate cancer patients were as the object of study,and divided into control group and observation group,each 33 cases in each group,the control group was treated with zoladex treatment,the observation group was treated with zoladex combined casodex treatment,compared two groups of patients with clinical curative effect and adverse reaction.Results Through the treatment of the control group of patients with adverse reactions occurred rate was 12.12% observed groups of patients with adverse reaction rate was 9.09%,the difference between no statistical significance（P〉 0.05）, two groups of patients with prostate specific antigen value compared to the observation group was significantly better than the control group andP〈 0.05, the difference was statisticaly significant.Conclusion The clinical use of zoladex combined casodex treatment of prostate cancer is a kind of effective method,has a good therapeutic effect and using the resistance and high safety.
出处
《中国卫生标准管理》
2015年第20期97-98,共2页
China Health Standard Management
